Efficacy of curcumin on prevention of drug-induced nephrotoxicity: A review of animal studies
dc.creator | Motaharinia J. | |
dc.creator | Panahi Y. | |
dc.creator | Barreto G.E. | |
dc.creator | Beiraghdar F. | |
dc.creator | Sahebkar A. | |
dc.date.accessioned | 2020-09-02T22:23:43Z | |
dc.date.accessioned | 2022-11-08T20:28:16Z | |
dc.date.available | 2020-09-02T22:23:43Z | |
dc.date.available | 2022-11-08T20:28:16Z | |
dc.date.created | 2020-09-02T22:23:43Z | |
dc.date.issued | 2019 | |
dc.identifier | 45, 5, 690-702 | |
dc.identifier | 09516433 | |
dc.identifier | https://hdl.handle.net/20.500.12728/5457 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5146754 | |
dc.language | en | |
dc.publisher | Blackwell Publishing Inc. | |
dc.subject | acute kidney injury | |
dc.subject | Curcuma longa | |
dc.subject | Curcumin | |
dc.subject | nephroprotection | |
dc.subject | nephrotoxicity | |
dc.subject | creatinine | |
dc.subject | curcumin | |
dc.subject | nitrogen | |
dc.subject | urea | |
dc.subject | antiinflammatory agent | |
dc.subject | antioxidant | |
dc.subject | curcumin | |
dc.subject | methotrexate | |
dc.subject | paracetamol | |
dc.subject | clinical assessment | |
dc.subject | clinical effectiveness | |
dc.subject | clinical trial (topic) | |
dc.subject | creatinine blood level | |
dc.subject | drug bioavailability | |
dc.subject | drug efficacy | |
dc.subject | drug exposure | |
dc.subject | drug induced disease | |
dc.subject | drug utilization | |
dc.subject | histopathology | |
dc.subject | human | |
dc.subject | inflammation | |
dc.subject | kidney function | |
dc.subject | kidney injury | |
dc.subject | methodology | |
dc.subject | nephrotoxicity | |
dc.subject | nonhuman | |
dc.subject | optimal drug dose | |
dc.subject | oxidative stress | |
dc.subject | primary prevention | |
dc.subject | priority journal | |
dc.subject | regulatory mechanism | |
dc.subject | renal protection | |
dc.subject | Review | |
dc.subject | risk assessment | |
dc.subject | urea nitrogen blood level | |
dc.subject | acute kidney failure | |
dc.subject | animal | |
dc.subject | bioavailability | |
dc.subject | chemistry | |
dc.subject | Curcuma | |
dc.subject | drug administration | |
dc.subject | drug effect | |
dc.subject | isolation and purification | |
dc.subject | kidney | |
dc.subject | kidney function test | |
dc.subject | metabolism | |
dc.subject | oral drug administration | |
dc.subject | pathology | |
dc.subject | rat | |
dc.subject | Acetaminophen | |
dc.subject | Acute Kidney Injury | |
dc.subject | Administration, Oral | |
dc.subject | Animals | |
dc.subject | Anti-Inflammatory Agents | |
dc.subject | Antioxidants | |
dc.subject | Biological Availability | |
dc.subject | Curcuma | |
dc.subject | Curcumin | |
dc.subject | Drug Administration Schedule | |
dc.subject | Humans | |
dc.subject | Kidney | |
dc.subject | Kidney Function Tests | |
dc.subject | Methotrexate | |
dc.subject | Rats | |
dc.title | Efficacy of curcumin on prevention of drug-induced nephrotoxicity: A review of animal studies | |
dc.type | Review |